Lactic acid bacteria: prominent player in the fight against human pathogens

References

• Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016 Dec;8(1):1–1.
   PubMedGoogle Scholar
• Bagchi T. Traditional food & modern lifestyle: impact of probiotics. Indian J Med Res. 2014 Sep;140(3):333.
   PubMedGoogle Scholar
• Hill C, Guarner F, Reid G, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Clin Pract Gastroenterol Hepatol. 2014;11(8):506–514.
   Google Scholar
• Ilango S, Antony U. Probiotic microorganisms from non-dairy traditional fermented foods. Trends Food SciTechnol. 2021 Dec 1;118:617–638.
   Web of Science ®Google Scholar
• Metchnikoff E. Lactic acid as inhibiting intestinal putrefaction. The prolongation of life: optimistic studies. London: W. Heinemann; 1907. p. 161–183.
   Google Scholar
• Metchnikoff E. The nature of man: studies in optimistic philosophy. In: Mitchell, P. Chalmers, editor. New York and London: GP Putnam’s sons; 1903.
   Google Scholar
• Tissier H. Traitement des infections intestinales par la méthode de transformation de la flore bactérienne de l’intestin. Crit Rev Soc Biol. 1907;60:359–361.
   Google Scholar
• Georgieva R, Yocheva L, Tserovska L, et al. Antimicrobial activity and antibiotic susceptibility of Lactobacillus and Bifidobacterium spp. intended for use as starter and probiotic cultures. Biotechnol Biotechnol Equip. 2015 Jan 2;29(1):84–91.
   PubMed Web of Science ®Google Scholar
• Inglin RC, Stevens MJ, Meile L, et al. High-throughput screening assays for antibacterial and antifungal activities of Lactobacillus species. J Microbiol Methods. 2015 Jul 1;114:26–29.
   PubMed Web of Science ®Google Scholar
• EFSA - European Food Safety Authority. Update of the list of QPS-recommended 462 biological agents intentionally added to food or feed as notified to EFSA 4: suitability of 463 taxonomic units notified to EFSA until March 2016. EFSA J. 2016a;14:4522.
   Google Scholar
• Morovic W, Roper JM, Smith AB, et al. Safety evaluation of HOWARU® Restore (Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity. Food Chem Toxicol. 2017;110:316–324.
   PubMed Web of Science ®Google Scholar
• Sun Z, Yu J, Dan T, et al. Phylogenesis and evolution of lactic acid bacteria. In: Zhang H, Yimin C, editors. Lactic acid bacteria. Dordrecht: Springer; 2014. p. 1–101.
   Google Scholar
• Pot B, Felis GE, De Bruyne K, et al. The genus Lactobacillus, p 249–353. Lactic acid bacteria: biodiversity and taxonomy. Hoboken: NJ: John Wiley & Sons, Inc; 2014.
   Google Scholar
• Oberg TS, McMahon DJ, Culumber MD, et al. Invited review: review of taxonomic changes in dairy-related lactobacilli. J Dairy Sci. 2022 Feb 25;105(4):2750–2770.
   PubMed Web of Science ®Google Scholar
• Collins MD, Rodrigues U, Ash C, et al. Phylogenetic analysis of the genus Lactobacillus and related lactic acid bacteria as determined by reverse transcriptase sequencing of 16S rRNA. FEMS Microbiol Lett. 1991 Jan 1;77(1):5–12.
   Web of Science ®Google Scholar
• Zheng J, Ruan L, Sun M, et al. A genomic view of lactobacilli and pediococci demonstrates that phylogeny matches ecology and physiology. Appl Environ Microbiol. 2015 Oct 15;81(20):7233–7243.
   PubMed Web of Science ®Google Scholar
• Zheng J, Wittouck S, Salvetti E, et al. A taxonomic note on the genus Lactobacillus: description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int J Syst Evol Microbiol. 2020 Apr 1;70(4):2782–2858.
   PubMed Web of Science ®Google Scholar
• Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014 Mar 27;157(1):121–141.
   PubMed Web of Science ®Google Scholar
• Walter J, Britton RA, Roos S. Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proc Nat Acad Sci. 2011 Mar 15;108(supplement_1):4645–4652.
   PubMedGoogle Scholar
• Hervert-Hernández D, Goñi I. Dietary polyphenols and human gut microbiota: a review. Food Rev Int. 2011 Feb 28;27(2):154–169.
   Web of Science ®Google Scholar
• Mallett AK, Bearne CA, Rowland IR. The influence of incubation pH on the activity of rat and human gut flora enzymes. J Appl Bacteriol. 1989 May;66(5):433–437.
   PubMedGoogle Scholar
• Blaak EE, Canfora EE, Theis S, et al. Short chain fatty acids in human gut and metabolic health. Benef Microbes. 2020;11(5):411–455.
   PubMed Web of Science ®Google Scholar
• Magalhaes JG, Tattoli I, Girardin SE. The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens. Semin Immunol. 2007 Apr 1;19(2):106–115. Academic Press
   PubMed Web of Science ®Google Scholar
• Blaut M, Klaus S. Intestinal microbiota and obesity. Appetite Control. 2012;209:251–273.
   Google Scholar
• McGuckin MA, Lindén SK, Sutton P, et al. Mucin dynamics and enteric pathogens. Nature Rev Microbiol. 2011 Apr;9(4):265–278.
   PubMed Web of Science ®Google Scholar
• Gill HS. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2003 Oct 1;17(5):755–773.
   PubMed Web of Science ®Google Scholar
• Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut. 2003 Jul 1;52(7):988–997.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhu YH, Yang JC, et al. A selected Lactobacillus rhamnosus strain promotes EGFR-independent Akt activation in an enterotoxigenic Escherichia coli K88-infected IPEC-J2 cell model. PloS one. 2015 Apr 27;10(4):e0125717.
   PubMed Web of Science ®Google Scholar
• Schlee M, Harder J, Köten B, et al. Probiotic lactobacilli and VSL# 3 induce enterocyte β-defensin 2. Clin Exp Immunol. 2008 Mar;151(3):528–535.
   PubMed Web of Science ®Google Scholar
• Wilson KH, Perini F. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun. 1988 Oct;56(10):2610–2614.
   PubMed Web of Science ®Google Scholar
• Sanders ME, Benson A, Lebeer S, et al. Shared mechanisms among probiotic taxa: implications for general probiotic claims. Curr Opin Biotechnol. 2018 Feb 1;49:207–216.
   PubMed Web of Science ®Google Scholar
• Zuo F, Appaswamy A, Gebremariam HG, et al. Role of Sortase A in lactobacillus gasseri Kx110A1 adhesion to gastric epithelial cells and competitive exclusion of helicobacter pylori. Front Microbiol. 2019 Dec 3;10:2770.
   PubMed Web of Science ®Google Scholar
• Mohanty D, Panda S, Kumar S, et al. In vitro evaluation of adherence and anti-infective property of probiotic Lactobacillus plantarum DM 69 against Salmonella enterica. Microb Pathog. 2019 Jan 1;126:212–217.
   PubMed Web of Science ®Google Scholar
• Russell JB, Diez-Gonzalez F. The effects of fermentation acids on bacterial growth. Adv Microb Physiol. 1997 Jan 1;39:205–234.
   Web of Science ®Google Scholar
• Salminen S, Ouwehand AC, Isolauri E. Clinical applications of probiotic bacteria. Int Dairy J. 1998 May 1;8(5–6):563–572.
   Web of Science ®Google Scholar
• Mokoena MP. Lactic acid bacteria and their bacteriocins: classification, biosynthesis and applications against uropathogens: a mini-review. Molecules. 2017 Jul 26;22(8):1255.
   PubMed Web of Science ®Google Scholar
• Yang SC, Lin CH, Sung CT, et al. Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front Microbiol. 2014 May 26;5:241.
   PubMed Web of Science ®Google Scholar
• Mitchell C, Fredricks D, Agnew K, et al. Hydrogen-peroxide producing lactobacilli are associated with lower levels of vaginal IL1β, independent of bacterial vaginosis. Sex Transm Dis. 2015 Jul;42(7):358.
   PubMed Web of Science ®Google Scholar
• Finnegan M, Linley E, Denyer SP, et al. Mode of action of hydrogen peroxide and other oxidizing agents: differences between liquid and gas forms. J Antimicrob Chemother. 2010 Oct 1;65(10):2108–2115.
   PubMed Web of Science ®Google Scholar
• Cristofori F, Dargenio VN, Dargenio C, et al. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front Immunol. 2021 Feb 26;12:178.
   Web of Science ®Google Scholar
• Nazir Y, Hussain SA, Abdul Hamid A, et al. Probiotics and their potential preventive and therapeutic role for cancer, high serum cholesterol, and allergic and HIV diseases. BioMed research international. 2018Aug 29; 2018.
   Google Scholar
• Saxelin M, Tynkkynen S, Mattila-Sandholm T, et al. Probiotic and other functional microbes: from markets to mechanisms. Curr Opin Biotechnol. 2005 Apr 1;16(2):204–211.
   PubMed Web of Science ®Google Scholar
• Abreu MT, Arditi M. Innate immunity and toll-like receptors: clinical implications of basic science research. J Pediatr. 2004 Apr 1;144(4):421–429.
   PubMed Web of Science ®Google Scholar
• Gómez-Llorente C, Munoz S, Gil A. Role of Toll-like receptors in the development of immunotolerance mediated by probiotics. Proc Nutr Soc. 2010 Aug;69(3):381–389.
   PubMed Web of Science ®Google Scholar
• Rhayat L, Maresca M, Nicoletti C, et al. Effect of Bacillus subtilis strains on intestinal barrier function and inflammatory response. Front Immunol. 2019 Mar 29;10:564.
   PubMed Web of Science ®Google Scholar
• Haller D, Bode C, Hammes WP, et al. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut. 2000;47(1):79–87.
   PubMed Web of Science ®Google Scholar
• Marelli G, Papaleo E, Ferrari A. Lactobacilli for prevention of urogenital infections: a review. Eur Rev Med Pharmacol Sci. 2004 Mar 1;8(2):87–96.
   PubMedGoogle Scholar
• Abad CL, Safdar N. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections–a systematic review. J Chemother. 2009 Jun 1;21(3):243–252.
   PubMed Web of Science ®Google Scholar
• Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001 Jul 3;135(1):41–50.
   PubMed Web of Science ®Google Scholar
• Gupta K, Sahm DF, Mayfield D, et al. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clinl Infect Dis. 2001 Jul 1;33(1):89–94.
   PubMed Web of Science ®Google Scholar
• Onderdonk AB, Delaney ML, Fichorova RN. The human microbiome during bacterial vaginosis. Clin Microbiol Rev. 2016 Apr;29(2):223–238.
   PubMed Web of Science ®Google Scholar
• Cauci S, Driussi S, De Santo D, et al. Prevalence of bacterial vaginosis and vaginal flora changes in peri-and postmenopausal women. J Clin Microbiol. 2002 Jun;40(6):2147–2152.
   PubMed Web of Science ®Google Scholar
• Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005 Nov 3;353(18):1899–1911.
   PubMed Web of Science ®Google Scholar
• Bautista CT, Wurapa E, Sateren WB, et al. Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil Med Res. 2016 Dec;3(1):1–0.
   PubMedGoogle Scholar
• De Gregorio PR, Tomás MS, Terraf MC, et al. In vitro and in vivo effects of beneficial vaginal lactobacilli on pathogens responsible for urogenital tract infections. J Med Microbiol. 2014 May 1;63(5):685–696.
   PubMedGoogle Scholar
• Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet. 2014 Mar;289(3):479–489.
   PubMed Web of Science ®Google Scholar
• Van De Wijgert JH, Borgdorff H, Verhelst R, et al. The vaginal microbiota: what have we learned after a decade of molecular characterization? PloS one. 2014 Aug 22;9(8):e105998.
   PubMed Web of Science ®Google Scholar
• Wilson M. Microbial inhabitants of humans: their ecology and role in health and disease. United Kingdom: Cambridge University Press; 2005.
   Google Scholar
• Asahara T, Nomoto K, Watanuki M, et al. Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother. 2001;45(6):1751–1760.
   PubMed Web of Science ®Google Scholar
• Reid G, Bruce AW. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis. 2001 Mar 1;183(Supplement_1):S77–80.
   PubMedGoogle Scholar
• Cadieux PA, Burton J, Devillard E, et al. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol. 2009 Dec 1;60(Suppl 6):13–18.
   PubMedGoogle Scholar
• de Llano DG, Arroyo A, Cárdenas N, et al. Strain-specific inhibition of the adherence of uropathogenic bacteria to bladder cells by probiotic Lactobacillus spp. Pathog Dis. 2017 Jun;75(4):ftx043.
   Web of Science ®Google Scholar
• Scillato M, Spitale A, Mongelli G, et al. Antimicrobial properties of Lactobacillus cell‐free supernatants against multidrug‐resistant urogenital pathogens. Microbiologyopen. 2021 Apr;10(2):e1173.
   PubMed Web of Science ®Google Scholar
• Mohammed BJ, Kadhim AA. In vitro determining the effect of vaginal lactobacillus on some pathogenic of urogenital infections in women. Plant Arch. 2020;20(1):2980–2984.
   Google Scholar
• Zárate G, Santos V, Nader-Macias ME. Protective effect of vaginal lactobacillus paracasei CRL 1289 against urogenital infection produced by staphylococcus aureus in a mouse animal model. Infect Dis Obstet Gynecol. 2007 Oct;2007:1–6.
   Google Scholar
• Shim YH, Lee SJ, Lee JW. Antimicrobial activity of lactobacillus strains against uropathogens. Pediatr Int. 2016 Oct;58(10):1009–1013.
   PubMed Web of Science ®Google Scholar
• Mastromarino P, Macchia S, Meggiorini L, et al. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect. 2009 Jan 1;15(1):67–74.
   PubMed Web of Science ®Google Scholar
• Larsson PG, Stray-Pedersen B, Ryttig KR, et al. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Women’s Health. 2008 Dec;8(1):1–8.
   PubMedGoogle Scholar
• Mastromarino P, Di Pietro M, Schiavoni G, et al. Effects of vaginal lactobacilli in Chlamydia trachomatis infection. Int J Med Microbiol. 2014 Jul 1;304(5–6):654–661.
   PubMed Web of Science ®Google Scholar
• Nardini P, Ñahui Palomino RA, Parolin C, et al. Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study. Sci Rep. 2016 Jun 29;6(1):1–1.
   PubMedGoogle Scholar
• Saunders S, Bocking A, Challis J, et al. Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms. Colloids Surf B Biointerfaces. 2007 Apr 1;55(2):138–142.
   PubMed Web of Science ®Google Scholar
• Aroutcheva AA, Simoes JA, Faro S. Antimicrobial protein produced by vaginal Lactobacillus acidophilus that inhibits Gardnerella vaginalis. Infect Dis Obstet Gynecol. 2001 Jan 1;9(1):33–39.
   PubMedGoogle Scholar
• Spurbeck RR, Arvidson CG. Inhibition of Neisseria gonorrhoeae epithelial cell interactions by vaginal Lactobacillus species. Infect Immun. 2008 Jul;76(7):3124–3130.
   PubMed Web of Science ®Google Scholar
• El-Mokhtar MA, Hassanein KM, Ahmed AS, et al. Antagonistic activities of cell-free supernatants of lactobacilli against extended-spectrum β-lactamase producing Klebsiella pneumoniae and Pseudomonas aeruginosa. Infect Drug Resist. 2020;13:543.
   PubMed Web of Science ®Google Scholar
• McGroarty JA, Reid G. Detection of a Lactobacillus substance that inhibits Escherichia coli. Can J Microbiol. 1988 Aug 1;34(8):974–978.
   PubMed Web of Science ®Google Scholar
• Ocaña VS, Pesce de Ruiz Holgado AA, Nader-Macías ME. Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain. Appl Environ Microbiol. 1999 Dec 1;65(12):5631–5635.
   PubMed Web of Science ®Google Scholar
• De Gregorio PR, Juárez Tomás MS, Leccese Terraf MC, et al. Preventive effect of L actobacillus reuteri CRL 1324 on G roup BS treptococcus vaginal colonization in an experimental mouse model. J Appl Microbiol. 2015 Apr;118(4):1034–1047.
   PubMed Web of Science ®Google Scholar
• Baker CJ. Group B streptococcal infections. Clin Perinatol. 1997 Mar 1;24(1):59–70.
   PubMed Web of Science ®Google Scholar
• De Seta F, Parazzini F, De Leo R, et al. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study. Eur J Obstetrics Gynecol Reprod Biol. 2014 Nov 1;182:136–139.
   PubMed Web of Science ®Google Scholar
• Murina F, Graziottin A, Vicariotto F, et al. Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis?: a clinical study. J Clin Gastroenterol. 2014 Nov 1;48(Supplement 1):S102–5.
   PubMedGoogle Scholar
• Spurbeck RR, Arvidson CG. Lactobacillus jensenii surface-associated proteins inhibit Neisseria gonorrhoeae adherence to epithelial cells. Infect Immun. 2010 Jul;78(7):3103–3111.
   PubMed Web of Science ®Google Scholar
• Ng QX, Peters C, Venkatanarayanan N, et al. Use of Lactobacillus spp. to prevent recurrent urinary tract infections in females. Med Hypotheses. 2018;114:49–54.
   PubMed Web of Science ®Google Scholar
• Chan JS, Chao AC, Cheung VC, et al. Gastrointestinal disease burden and mortality: a public hospital‐based study from 2005 to 2014. J Gastroenterol Hepatol. 2019 Jan;34(1):124–131.
   PubMed Web of Science ®Google Scholar
• Panduro A, Rivera-Iñiguez I, Sepulveda-Villegas M, et al. Genes, emotions and gut microbiota: the next frontier for the gastroenterologist. World J Gastroenterol. 2017 May 7;23(17):3030.
   PubMed Web of Science ®Google Scholar
• Gupta T, Kaur H, Kapila S, et al. Lactobacillus fermentum (MTCC‐5898) alleviates Escherichia coli‐induced inflammatory responses in intestinal epithelial cells by modulating immune genes and NF‐κB signalling. J Appl Microbiol. 2021 Dec;131(6):3008–3017.
   PubMed Web of Science ®Google Scholar
• Isolauri E. Probiotics for infectious diarrhoea. Gut. 2003 Mar 1;52(3):436–437.
   PubMed Web of Science ®Google Scholar
• Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr. 2001 Oct 1;33:S17–25.
   PubMed Web of Science ®Google Scholar
• Konstantinov SR, Smidt H, Akkermans AD, et al. Feeding of Lactobacillus sobrius reduces Escherichia coli F4 levels in the gut and promotes growth of infected piglets. FEMS Microbiol Ecol. 2008 Dec 1;66(3):599–607.
   PubMed Web of Science ®Google Scholar
• Vidal K, Donnet-Hughes A, Granato D. Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria. Infect Immun. 2002 Apr;70(4):2057–2064.
   PubMed Web of Science ®Google Scholar
• Sakamoto I, Igarashi M, Kimura K, et al. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother. 2001 May 1;47(5):709–710.
   PubMed Web of Science ®Google Scholar
• Lionetti E, Miniello VL, Castellaneta SP, et al. Lactobacillus reuteri therapy to reduce side‐effects during anti‐Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment Pharmacol Ther. 2006 Nov;24(10):1461–1468.
   PubMed Web of Science ®Google Scholar
• Eom JS, Song J, Choi HS. Protective effects of a novel probiotic strain of Lactobacillus plantarum JSA22 from traditional fermented soybean food against infection by Salmonella enterica serovar Typhimurium. J Microbiol Biotechnol. 2015;25(4):479–491.
   PubMed Web of Science ®Google Scholar
• Jankowska A, Laubitz D, Antushevich H, et al. Competition of Lactobacillus paracasei with Salmonella enterica for adhesion to Caco-2 cells. J Biomed Biotechnol. 2008 Oct;2008:1–6.
   Google Scholar
• Pridmore RD, Pittet AC, Praplan F, et al. Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity. FEMS Microbiol Lett. 2008 Jun 1;283(2):210–215.
   PubMed Web of Science ®Google Scholar
• Das JK, Mishra D, Ray P, et al. In vitro evaluation of anti-infective activity of a Lactobacillus plantarum strain against Salmonella enterica serovar Enteritidis. Gut Pathog. 2013 Dec;5(1):1–1.
   PubMedGoogle Scholar
• Chen X, Liu XM, Tian F, et al. Antagonistic activities of lactobacilli against Helicobacter pylori growth and infection in human gastric epithelial cells. J Food Sci. 2012 Jan;77(1):M9–14.
   PubMed Web of Science ®Google Scholar
• Patel A, Shah N, Prajapati JB. Clinical application of probiotics in the treatment of Helicobacter pylori infection—a brief review. J Microbiol Immunol Infect. 2014 Oct 1;47(5):429–437.
   PubMedGoogle Scholar
• Marteau P, Seksik P, Jian R. Probiotics and intestinal health effects: a clinical perspective. Br J Nutr. 2002 Sep;88(S1):s51–7.
   PubMedGoogle Scholar
• Felley CP, Corthésy-Theulaz I, Rivero JL, et al. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol. 2001 Jan 1;13(1):25–29.
   PubMed Web of Science ®Google Scholar
• de Klerk N, Maudsdotter L, Gebreegziabher H, et al. Lactobacilli reduce Helicobacter pylori attachment to host gastric epithelial cells by inhibiting adhesion gene expression. Infect Immun. 2016 Feb 29;84(5):1526–1535.
   PubMed Web of Science ®Google Scholar
• Yoda K, He F, Kawase M, et al. Oral administration of Lactobacillus gasseri TMC0356 stimulates peritoneal macrophages and attenuates general symptoms caused by enteropathogenic Escherichia coli infection. J Microbiol Immunol Infect. 2014;47(2):81–86.
   PubMedGoogle Scholar
• Castillo NA, de Leblanc AD, Galdeano CM, et al. Probiotics: an alternative strategy for combating salmonellosis: immune mechanisms involved. Food Res Int. 2012 Mar 1;45(2):831–841.
   Web of Science ®Google Scholar
• Liu J, Gu Z, Song F, et al. Lactobacillus plantarum ZS2058 and Lactobacillus rhamnosus GG use different mechanisms to prevent Salmonella infection in vivo. Front Microbiol. 2019 Feb 20;10:299.
   PubMed Web of Science ®Google Scholar
• Kemgang TS, Kapila S, Shanmugam VP, et al. Fermented milk with probiotic Lactobacillus rhamnosus S1K3 (MTCC5957) protects mice from salmonella by enhancing immune and nonimmune protection mechanisms at intestinal mucosal level. J Nutr Biochem. 2016 Apr 1;30:62–73.
   PubMed Web of Science ®Google Scholar
• Li N, Pang B, Li J, et al. Mechanisms for Lactobacillus rhamnosus treatment of intestinal infection by drug-resistant Escherichia coli. Food Funct. 2020;11(5):4428–4445.
   PubMed Web of Science ®Google Scholar
• Kumamoto CA. Inflammation and gastrointestinal Candida colonization. Curr Opin Microbiol. 2011 Aug 1;14(4):386–391.
   PubMed Web of Science ®Google Scholar
• Authier H, Salon M, Rahabi M, et al. Oral Administration of Lactobacillus helveticus LA401 and Lactobacillus gasseri LA806 combination attenuates oesophageal and gastrointestinal candidiasis and consequent gut inflammation in mice. J Fungi. 2021 Jan 15;7(1):57.
   Web of Science ®Google Scholar
• Farthing MJ. Treatment options for the eradication of intestinal protozoa. Nat Clin Pract Gastroenterol Hepatol. 2006 Aug;3(8):436–445.
   PubMedGoogle Scholar
• Shukla G, Devi P, Sehgal R. Effect of Lactobacillus casei as a probiotic on modulation of giardiasis. Dig Dis Sci. 2008 Oct;53(10):2671–2679.
   PubMed Web of Science ®Google Scholar
• Alak JI, Wolf BW, Mdurvwa EG, et al. Effect of Lactobacillus reuteri on intestinal resistance to Cryptosporidium parvum infection in a murine model of acquired immunodeficiency syndrome. J Infect Dis. 1997 Jan 1;175(1):218–221.
   PubMed Web of Science ®Google Scholar
• Hammerschmidt S, Bethe G,H, Remane P, et al. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. Infect Immun. 1999 Apr 1;67(4):1683–1687.
   PubMed Web of Science ®Google Scholar
• Villena J, Racedo S, Agüero G, et al. Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J Nutr. 2005 Jun 1;135(6):1462–1469.
   PubMed Web of Science ®Google Scholar
• Saroj SD, Maudsdotter L, Tavares R, et al. Lactobacilli interfere with Streptococcus pyogenes hemolytic activity and adherence to host epithelial cells. Front Microbiol. 2016 Jul 29;7:1176.
   PubMed Web of Science ®Google Scholar
• Salva S, Villena J, Alvarez S. Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: impact on intestinal and respiratory infections. Int J Food Microbiol. 2010 Jun 30;141(1–2):82–89.
   PubMed Web of Science ®Google Scholar
• Racedo S, Villena J, Medina M, et al. Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice. Microbes Infect. 2006 Aug 1;8(9–10):2359–2366.
   PubMed Web of Science ®Google Scholar
• Tanaka A, Seki M, Yamahira S, et al. Lactobacillus pentosus strain b240 suppresses pneumonia induced by Streptococcus pneumoniae in mice. Lett Appl Microbiol. 2011 Jul;53(1):35–43.
   PubMed Web of Science ®Google Scholar
• Shoaib A, Xin L, Xin Y. Oral administration of Lactobacillus acidophilus alleviates exacerbations in Pseudomonas aeruginosa and Staphylococcus aureus pulmonary infections. Pak J Pharm Sci. 2019 Jul 1;32(4):1621–1630.
   PubMed Web of Science ®Google Scholar
• Kiso M, Takano R, Sakabe S, et al. Protective efficacy of orally administered, heat-killed Lactobacillus pentosus b240 against influenza A virus. Sci Rep. 2013 Mar 28;3(1):1–8.
   Google Scholar
• Hojsak I, Abdović S, Szajewska H, et al. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics. 2010 May;125(5):e1171–7.
   PubMed Web of Science ®Google Scholar
• Chiba E, Tomosada Y, Vizoso-Pinto MG, et al. Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection. Int Immunopharmacol. 2013 Oct 1;17(2):373–382.
   PubMed Web of Science ®Google Scholar
• Alexandre Y, Le Berre R, Barbier G, et al. Screening of Lactobacillus spp. for the prevention of Pseudomonas aeruginosa pulmonary infections. BMC Microbiol. 2014 Dec;14(1):1–0.
   Google Scholar
• Harata G, He F, Hiruta N, et al. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett Appl Microbiol. 2010 Jun;50(6):597–602.
   PubMed Web of Science ®Google Scholar
• Van den Broek MF, De Boeck I, Claes IJ, et al. Multifactorial inhibition of lactobacilli against the respiratory tract pathogen Moraxella catarrhalis. Benef Microbes. 2018 Apr 25;9(3):429–439.
   PubMed Web of Science ®Google Scholar
• Eguchi K, Fujitani N, Nakagawa H, et al. Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055. Sci Rep. 2019 Mar 18;9(1):1–1.
   PubMedGoogle Scholar
• Fangous MS, Alexandre Y, Hymery N, et al. Lactobacilli intra-tracheal administration protects from Pseudomonas aeruginosa pulmonary infection in mice–a proof of concept. Benef Microbes. 2019 Dec 9;10(8):893–900.
   PubMed Web of Science ®Google Scholar
• Vareille-Delarbre M, Miquel S, Garcin S, et al. Immunomodulatory effects of Lactobacillus plantarum on inflammatory response induced by Klebsiella pneumoniae. Infect Immun. 2019 Oct 18;87(11):e00570–19.
   PubMed Web of Science ®Google Scholar
• Lavania M, Potdar VA, Ranshing S, et al. Whole-genome sequencing & mutational analysis of SARS-CoV-2 from patients’ faecal samples reveal the possible role in faecal-oral transmission. Indian J Med Res. 2022 May 27;155(1):205.
   PubMed Web of Science ®Google Scholar
• Rather IA, Choi SB, Kamli MR, et al. Potential adjuvant therapeutic effect of lactobacillus plantarum probio-88 postbiotics against SARS-CoV-2. Vaccines (Basel). 2021 Sep 24;9(10):1067.
   PubMed Web of Science ®Google Scholar
• Salaris C, Scarpa M, Elli M, et al. Lacticaseibacillus paracasei DG enhances the lactoferrin anti-SARS-CoV-2 response in Caco-2 cells. Gut Microbes. 2021 Jan 1;13(1):1961970.
   PubMed Web of Science ®Google Scholar
• Delanghe L, Spacova I, Van Malderen J, et al. The role of lactobacilli in inhibiting skin pathogens. Biochem Soc Trans. 2021 Apr 30;49(2):617–627.
   PubMed Web of Science ®Google Scholar
• Sikorska H, Smoragiewicz W. Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents. 2013 Dec 1;42(6):475–481.
   PubMed Web of Science ®Google Scholar
• Prince T, McBain AJ, O’Neill CA. Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus-induced cell death by competitive exclusion. Appl Environ Microbiol. 2012 Aug 1;78(15):5119–5126.
   PubMed Web of Science ®Google Scholar
• Jebur MS. Therapeutic efficacy of Lactobacillus acidophilus against bacterial isolates from burn wounds. N Am J Med Sci. 2010 Dec;2(12):586.
   PubMedGoogle Scholar
• Karska-Wysocki B, Bazo M, Smoragiewicz W. Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). Microbiol Res. 2010 Oct 20;165(8):674–686.
   PubMed Web of Science ®Google Scholar
• Fahad HJ, Radeef HM. Capability of Lactobacillus acidophilus supernatant to inhibit production of lipase from methicillin-resistant Staphylococcus aureus. J Univ Of Anbar For Pure Sci. 2011;5(2):1–5.
   Google Scholar
• Valdez JC, Peral MC, Rachid M, et al. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment. Clin Microbiol Infect. 2005 Jun 1;11(6):472–479.
   PubMed Web of Science ®Google Scholar
• Onbas T, Osmanagaoglu O, Kiran F. Potential properties of Lactobacillus plantarum F-10 as a bio-control strategy for wound infections. Probiotics Antimicrob Proteins. 2019 Dec;11(4):1110–1123.
   PubMed Web of Science ®Google Scholar
• Abootaleb M, Bandari NM, Soleimani NA. Interference of Lactobacillus casei with Pseudomonas aeruginosa in the treatment of infected burns in Wistar rats. Iran J Basic Med Sci. 2021 Feb;24(2):143.
   PubMed Web of Science ®Google Scholar
• Satish L, Gallo PH, Johnson S, et al. Local probiotic therapy with Lactobacillus plantarum mitigates scar formation in rabbits after burn injury and infection. Surg Infect (Larchmt). 2017 Feb 1;18(2):119–127.
   PubMed Web of Science ®Google Scholar
• Ong JS, Taylor TD, Yong CC, et al. Lactobacillus plantarum USM8613 aids in wound healing and suppresses Staphylococcus aureus infection at wound sites. Probiotics Antimicrob Proteins. 2020 Mar;12(1):125–137.
   PubMed Web of Science ®Google Scholar
• Guo J, Brosnan B, Furey A, et al. Antifungal activity of Lactobacillus against Microsporum canis, Microsporum gypseum and Epidermophyton floccosum. Bioengineered. 2012 Mar 1;3(2):104–113.
   Web of Science ®Google Scholar
• Onwuliri V, Agbakoba NR, Anukam KC. Topical cream containing live lactobacilli decreases malodor‐producing bacteria and downregulates genes encoding PLP‐dependent enzymes on the axillary skin microbiome of healthy adult Nigerians. J Cosmet Dermatol. 2021 Sep;20(9):2989–2998.
   PubMed Web of Science ®Google Scholar
• Jung GW, Tse JE, Guiha I, et al. Prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne. J Cutan Med Surg. 2013 Mar;17(2):114–122.
   PubMed Web of Science ®Google Scholar
• Naqvi SS, Nagendra V, Hofmeyr A. Probiotic related Lactobacillus rhamnosus endocarditis in a patient with liver cirrhosis. IDCases. 2018 Jan 1;13:e00439.
   PubMed Web of Science ®Google Scholar
• Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr. 2004 Apr 1;38(4):457–458.
   PubMed Web of Science ®Google Scholar
• Chiang MC, Chen CL, Feng Y, et al. Lactobacillus rhamnosus sepsis associated with probiotic therapy in an extremely preterm infant: pathogenesis and a review for clinicians. J Microbiol Immunol Infect. 2021 Aug 1;54(4):575–580.
   PubMedGoogle Scholar
• LeDoux D, LaBombardi VJ, Karter D. Lactobacillus acidophilus bacteraemia after use of a probiotic in a patient with AIDS and Hodgkin’s disease. Int J STD AIDS. 2006 Apr 1;17(4):280–282.
   PubMed Web of Science ®Google Scholar
• Sadowska-Krawczenko I, Paprzycka M, Korbal P, et al. Lactobacillus rhamnosus GG suspected infection in a newborn with intrauterine growth restriction. Benef Microbes. 2014 Dec 1;5(4):397–402.
   PubMed Web of Science ®Google Scholar
• Doern CD, Nguyen ST, Afolabi F, et al. Probiotic-associated aspiration pneumonia due to Lactobacillus rhamnosus. J Clin Microbiol. 2014 Aug;52(8):3124–3126.
   PubMed Web of Science ®Google Scholar
• Koyama S, Fujita H, Shimosato T, et al. Septicemia from Lactobacillus rhamnosus GG, from a probiotic enriched yogurt, in a patient with autologous stem cell transplantation. Probiotics Antimicrob Proteins. 2019 Mar;11(1):295–298.
   PubMed Web of Science ®Google Scholar
• Hor YY, Lew LC, Lau AS, et al. Probiotic Lactobacillus casei Zhang (LCZ) alleviates respiratory, gastrointestinal & RBC abnormality via immuno-modulatory, anti-inflammatory & anti-oxidative actions. J Funct Foods. 2018 May 1;44:235–245.
   Web of Science ®Google Scholar
• Salminen MK, Tynkkynen S, Rautelin H, et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clinl Infect Dis. 2002;35(10):1155–1160.
   PubMed Web of Science ®Google Scholar